financetom
Business
financetom
/
Business
/
Hubilo raises $4.5 mn from Lightspeed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hubilo raises $4.5 mn from Lightspeed
Oct 27, 2020 6:36 AM

Hubilo, a global virtual events platform, has raised USD 4.5 million (about Rs 33.2 crore) in funding, led by venture capital firm Lightspeed. Marquee tech angels, including Girish Mathrubootham (CEO Freshworks), Nishant Rao (ex-CEO LinkedIn India), Jonathan Boutelle (Co-founder, Slideshare), and Abinash Tripathy (CEO Helpshift) also participated in the seed funding round, Hubilo said in a statement late Monday night.

Share Market Live

NSE

The company, which started its journey amidst the COVID crisis in April, has grown over 40X organically and is projected to exceed USD 10 million in booking run rate and host over one million attendees in the next few months, it added. The USD 800 billion global events industry was one of the hardest hit by COVID-19 but organisers are migrating online rapidly and also expanding their attendee base.

Hubilo said it is building a ’system of record’ for virtual events. On one end, Hubilo offers gamified experiences to increase attendee engagement, and on the other end, it offers deep integrations with platforms such as Marketo and Salesforce to provide actionable insights to organisers and sponsors and they can see the return on investment from their event-related budgets. Customers like the United Nations, Roche, Informa Markets, Tech In Asia, Fortune and GITEX are already using Hubilo for their events, the statement said.

”Our vision is to build the world’s smartest platform for virtual events that brings Experience + Intelligence together. While the revenue growth has been phenomenal, what excites us most is re-imagining and leading the marketing stack that will emerge around virtual events and unlocking massive value for key stakeholders such as CMOs, event organisers and sponsors,” Vaibhav Jain, Founder and CEO of Hubilo, said.

First Published:Oct 27, 2020 2:36 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved